Keith Goldan

Keith Goldan

Director of Finance/CFO at SYNDAX PHARMACEUTICALS, INC.

Net worth: 3 M $ as of 30/07/2026

55 year
Health Technology
Consumer Services
Commercial Services

Profile

Keith Alan Goldan is the founder of Century Capital Associates.
Current positions include Independent Director at Abeona Therapeutics, Inc. starting in 2026 and Chief Financial Officer at Syndax Pharmaceuticals, Inc. starting in 2022.
Former roles include Chief Financial Officer & Director at Realm Therapeutics Plc from 2004 to 2008, CFO, Treasurer & Senior Vice President at Fibrocell Science, Inc. from 2015 to 2017, Chief Financial Officer at OptiNose, Inc. from 2017 to 2022, Chief Financial Officer at Cantel Medical (UK) Ltd., CFO, Vice President & Head-Investor Relations at NuPathe, Inc. from 2012 to 2013, and Chief Financial Officer & Vice President at Biosyn, Inc. Education includes undergraduate studies at Robert H.
Smith School of Business and an MBA from The Wharton School of the University of Pennsylvania.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/05/2026 139,252 ( 0.16% ) 3 M $ 30/07/2026
14/04/2026 32,751 ( 0.06% ) 210 261 $ 30/07/2026

Keith Goldan active positions

CompaniesPositionStart
SYNDAX PHARMACEUTICALS, INC. Director of Finance/CFO 12/06/2022
ABEONA THERAPEUTICS INC. Director/Board Member 31/03/2026

Former positions of Keith Goldan

CompaniesPositionEnd
OPTINOSEPAR Director of Finance/CFO 09/06/2022
FIBROCELL SCIENCE, INC. Director of Finance/CFO 31/12/2016
Director of Finance/CFO 30/10/2008
REALM THERAPEUTICS PLC Director of Finance/CFO 12/10/2008
Founder -
See the detail of Keith Goldan's experience

Training of Keith Goldan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

57

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Retail Trade

Consumer Services

Consumer Services